SCHEMBL5963345

SCHEMBL5963345

CCCCNCC1=C(c2ccc(Cl)cc2)S(=O)(=O)NC12CCCCC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
POLB P06746 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
FPR2 P25090 1/20 0.33
AKR1B1 P15121 1/20 0.32
HRH4 Q9H3N8 1/20 0.32
HRH3 Q9Y5N1 1/20 0.32
TP53 P04637 2/20 0.31
MDM2 Q00987 1/20 0.31
PDE7B Q9NP56 1/20 0.31
HDAC3 O15379 1/20 0.31
HDAC1 Q13547 1/20 0.31
HDAC2 Q92769 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31
LMNA P02545 1/20 0.31
KDM4E B2RXH2 1/20 0.31
THRB P10828 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
MITF O75030 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5963749 0.93 FPR2 (0.34) SMN1; SMN2FPR2AKR1B1ALDH1A1LMNA
SCHEMBL5964210 0.89 AKR1B1 (0.34) FPR2AKR1B1PDE7BALDH1A1LMNA
SCHEMBL5004858 0.88 AKR1B1 (0.33) FPR2AKR1B1PDE7BCNR1
SCHEMBL5007459 0.85 FPR2 (0.32) FPR2AKR1B1
SCHEMBL5963305 0.84 SLC6A3 (0.39) FPR2AKR1B1ALDH1A1LMNATHRB
SCHEMBL5964279 0.82 AKR1B1 (0.31) AKR1B1
SCHEMBL6820213 0.81 AKR1B1 (0.39) FPR2AKR1B1ALDH1A1HPGDLMNA
SCHEMBL5963569 0.81 KMT2A (0.38) AKR1B1TP53ALDH1A1LMNATHRB
SCHEMBL5963604 0.79 POLB (0.35) SMN1; SMN2POLBAKR1B1PDE7BALDH1A1
SCHEMBL5963772 0.78 AKR1B1 (0.33) FPR2AKR1B1ALDH1A1LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7125840-B2 Substituted dipeptides as growth hormone secretagogues ELI LILLY AND COMPANY (US) 2006-10-24 US disclosed
US-20040058971-A1 Substituted dipeptides as growth hormone secretagogues ELI LILLY AND COMPANY 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058971-A1 Substituted dipeptides as growth hormone secretagogues GHSR, GHRHR, SSTR4 SMN1; SMN2 3213/4885POLB 4556/4885L3MBTL1 2397/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.